Disease Team Applications Under Discussion
The $100 million disease team round applications are under discussion currently at today's meeting of the governing board of the California stem cell agency.
CIRM Chairman Jonathan Thomas outlined the appeal process prior to the discussion and cautioned rejected applicants in the audience that the board is not the first avenue of appeals.
The board has re…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.